生色肽底物。它们在纤溶系统和血浆激肽释放酶-激肽系统中因子测定中的应用。 - Suppr

Suppr

超能文献

Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.

作者信息

Friberger P

出版信息

Scand J Clin Lab Invest Suppl. 1982;162:1-298.

PMID:6221396

Abstract

摘要

相似文献

Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.

Scand J Clin Lab Invest Suppl. 1982;162:1-298.

Chromogenic peptide substrate assays in patients with multiple trauma.

Acta Chir Scand Suppl. 1982;509:69-72.

Fluorogenic peptide substrates for proteases in blood coagulation, kallikrein-kinin and fibrinolysis systems.

Adv Exp Med Biol. 1979;120A:147-63. doi: 10.1007/978-1-4757-0926-1_15.

[State of the fibrinolytic and kinin systems of the blood after physical loading].

Fiziol Zh SSSR Im I M Sechenova. 1980 Oct;66(10):1473-80.

Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.

Blood Coagul Fibrinolysis. 2009 Jul;20(5):325-32. doi: 10.1097/MBC.0b013e32832811f8.

Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.

Semin Thromb Hemost. 1983 Oct;9(4):281-300.

The kinin system: its relation to blood coagulation, fibrinolysis and the formed elements of the blood.

Rev Physiol Biochem Pharmacol. 1978;84:143-202. doi: 10.1007/BFb0030492.

Chromogenic peptide substrate assays for determining components of the plasma kallikrein system.

Scand J Clin Lab Invest Suppl. 1985;178:127-32.

[Use of chromogenic substrates for estimation of indicators of kallikrein-kinin and blood coagulation systems in blood plasma of patients with nephrotic syndrome].

Vopr Med Khim. 1983 Sep-Oct;29(5):96-9.

[Effect of exogenous histamine on the proteolytic activity, level of proteolysis inhibitors and on the state of the kallikrein-kinin system of the blood].

Patol Fiziol Eksp Ter. 1979 Jan-Feb(1):51-4.

引用本文的文献

Criteria for the Specific Measurement of Plasmin Inhibitor Activity Using an Enzymatic Procedure.

EJIFCC. 2001 Jul 22;13(2):61-66. eCollection 2001 Jul.

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin.

J Vis Exp. 2018 May 6(135):57642. doi: 10.3791/57642.

Assessment of oxidative/nitrative modifications of plasma proteins, selected ROTEM parameters and kinetics of fibrinogen polymerization in patients with multiple myeloma at diagnosis.

Med Oncol. 2017 Jan;34(1):4. doi: 10.1007/s12032-016-0856-3. Epub 2016 Nov 30.

Venom variation in hemostasis of the southern Pacific rattlesnake (Crotalus oreganus helleri): isolation of hellerase.

Comp Biochem Physiol C Toxicol Pharmacol. 2009 Apr;149(3):307-16. doi: 10.1016/j.cbpc.2008.08.007. Epub 2008 Sep 5.

Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.

J Clin Invest. 2005 Apr;115(4):879-87. doi: 10.1172/JCI23977.

Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes.

Clin Exp Immunol. 2004 Mar;135(3):497-504. doi: 10.1111/j.1365-2249.2004.02401.x.

Interleukin-1 beta upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT).

Arch Dermatol Res. 1996 Aug;288(9):554-8. doi: 10.1007/BF02505254.

Cytokine and coagulation characteristics of retrieved blood after arthroplasty.

Intensive Care Med. 1995 Dec;21(12):989-95. doi: 10.1007/BF01700660.

Proteolytic activity in pancreatic pseudocyst fluid.

Int J Pancreatol. 1994 Jun;15(3):201-8. doi: 10.1007/BF02924195.

The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.

J Clin Invest. 1993 Aug;92(2):978-83. doi: 10.1172/JCI116674.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验